ArticleCardiovascular diabetology2025

Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study.

Zinan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.